The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon

Citation
Er. Leight et B. Sugden, The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon, J VIROLOGY, 75(22), 2001, pp. 10709-10720
Citations number
62
Categorie Soggetti
Microbiology
Journal title
JOURNAL OF VIROLOGY
ISSN journal
0022538X → ACNP
Volume
75
Issue
22
Year of publication
2001
Pages
10709 - 10720
Database
ISI
SICI code
0022-538X(200111)75:22<10709:TCFORC>2.0.ZU;2-X
Abstract
Previously we have shown that the establishment of an oriP replicon is depe ndent on its epigenetic modification, which occurs in only 1 to 10% of prol iferating cells (E. R. Leight and B. Sugden, Mol. Cell. Biol. 21: 4149-4161 , 2001). To gain insights into the cis-acting requirements for the establis hment of oriP replicons, we monitored the replication of oriP plasmid deriv atives for several weeks following their introduction into cells. In EBNA-1 -positive 143B and H1299 cells, plasmids containing only the region of dyad symmetry (DS) of oriP replicated but were lost more rapidly from cells tha n were oriP plasmids, demonstrating that the family of repeats (FR) of oriP acts in cis to stimulate replication in these cells. Unexpectedly, we foun d that the DS plasmid was established efficiently in 293/EBNA-1 cells, bein g lost at a rate of only 8% per cell generation over 24 days posttransfecti on. However, plasmids containing the FR in addition to the DS of oriP repli cated but were lost at a rate of approximately 30% per cell generation in 2 93/EBNA-1 cells, indicating that the FR inhibits oriP's establishment in th is cell line. FR's enhancement of transcription of a promoter in cis and FR 's ability to inhibit replication fork movement do not account solely for o riP's inefficient establishment. In addition, DNA looping between FR and DS neither stimulates nor inhibits replication. Deletion of 11 EBNA-1 binding sites in the FR or replacement of the FR with DS sequences, however, does overcome the inhibitory activity of the FR, thereby allowing efficient esta blishment of the oriP derivative in 293/EBNA-1 cells.